Impact of EUS Guided Treatment of Gastric Varices
- Conditions
- Gastric Varices Bleeding
- Registration Number
- NCT05521685
- Lead Sponsor
- Indiana University
- Brief Summary
The purpose of the study is to determine the clinical impact of cyanoacrylate tissue adhesive treatment for Gastric Varices performed by Indiana University EUS physicians.
- Detailed Description
Using an IRB approved database (IU IRB#1209009522; NCT02037659), data collected from the database will be evaluated to identify complications, risk of rebleeding, death within 1 year of treatment, varices eradication and need for re-intervention associated with cyanoacrylate tissue adhesive (Dermabond) treatment performed by Indiana University Endoscopic Ultrasound (EUS) physicians.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 119
- Any subject enrolled into the existing database (IU IRB#1209009522; NCT02037659).
- Not enrolled into the database.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Impact of EUS guided treatment of Gastric varices post procedure complications and adverse events Complications reviewed at time of retrospective study. EUS-guided sclerotherapy done between November 2012 and December 2021 Retrospective data review to Determine post procedure complications and adverse events at 24h, between 2 and 7 days and between 8 and 30 days after the procedure. Additionally, tracking rebleeding after first and second EUS. Moreover, looking at eradication of GV rate on second endoscopy (considered eradicated if absent or if residual varices have no or minimal flow on doppler)eradication, and need for re-intervention following cyanoacrylate tissue adhesive treatment for Gastric Varices performed by IU EUS physicians.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Indiana University
🇺🇸Indianapolis, Indiana, United States